Anticorps Recombinant de lapin anti-CD73

CD73 Recombinant Antibody for WB, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

rat, souris

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

241541D12

N° de cat : 84434-6-PBS

Synonymes

Ecto-5'-nucleotidase, EC:3.1.3.99, 5'-nucleotidase, 5'-NT, 5'-deoxynucleotidase

---

Galerie de données de validation

• 

  WB analysis using 84434-6-RR (same clone as 84434-6-PBS)

  Various lysates were subjected to SDS PAGE followed by western blot with 84434-6-RR (CD73 antibody) at dilution of 1:10000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 84434-6-PBS in a different storage buffer formulation.

---

Informations sur le produit

84434-6-PBS cible CD73 dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons rat, souris

• Réactivité: rat, souris
• Hôte / Isotype: Lapin / IgG
• Clonalité: Recombinant
• Type: Anticorps
• Immunogène: FusionProtein
• Nom complet: 5' nucleotidase, ecto
• Masse moléculaire calculée: 64kDa
• Poids moléculaire observé: 63 kDa
• Numéro d’acquisition GenBank: NM_011851.4
• Symbole du gène: Nt5e
• Identification du gène (NCBI): 23959
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Protein A purfication
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

CD73, also known as ecto-5'-nucleotidase (5'-NT), is a 70-kDa, glycosyl-phosphatidylinositol-linked membrane-bound glycoprotein found in most tissues (PMID: 18404475; 20179192). CD73 is an ectoenzyme that catalyzes the dephosphorylation of AMP and other nucleoside monophosphates (PMID: 9553767). In the human immune system, CD73 is expressed on subsets of T and B cells, on germinal center follicular dendritic cells, and on thymic medullary reticular fibroblasts and epithelial cells (PMID: 2137649; 9553767). CD73 is highly expressed in many human solid tumors and is closely involved in cancer progression (PMID: 20179192).

{{ptg:RelatedPrimaryAntibodies}}